Analgesics (Pharmacies) - Malawi

  • Malawi
  • Revenue in the Analgesics market is projected to reach US$1.81m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.51%, resulting in a market volume of US$2.60m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.08 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Malawi is experiencing significant growth and development.

Customer preferences:
Malawian consumers have shown a growing preference for analgesics purchased from pharmacies. This preference can be attributed to the trust and reliability associated with pharmacies, as well as the availability of a wide range of products. Customers value the expertise and advice provided by pharmacists, which helps them make informed decisions about the most suitable analgesics for their needs. Furthermore, the convenience of purchasing analgesics from pharmacies, which are often located in easily accessible areas, is also a key factor driving customer preferences.

Trends in the market:
One of the major trends in the Analgesics (Pharmacies) market in Malawi is the increasing demand for over-the-counter (OTC) analgesics. This trend is driven by factors such as the rising awareness of self-care and the convenience of purchasing OTC analgesics without a prescription. Malawian consumers are increasingly seeking immediate relief from pain and discomfort, and OTC analgesics provide a quick and accessible solution. Moreover, the availability of a wide range of OTC analgesics in pharmacies caters to the diverse needs and preferences of consumers. Another notable trend in the market is the growing demand for natural and herbal analgesics. Malawian consumers are becoming more conscious of their health and are seeking alternative remedies for pain relief. Natural and herbal analgesics are perceived to have fewer side effects and are often seen as a safer option compared to conventional analgesics. This trend is also influenced by the global rise in the popularity of natural and herbal products.

Local special circumstances:
Malawi, being a low-income country, has a significant proportion of the population that relies on the public healthcare system. However, the public healthcare system often faces challenges such as limited availability of medicines. As a result, many individuals turn to private pharmacies to access the necessary analgesics. This reliance on private pharmacies has contributed to the growth of the Analgesics (Pharmacies) market in Malawi.

Underlying macroeconomic factors:
The growing Analgesics (Pharmacies) market in Malawi can be attributed to several macroeconomic factors. Firstly, the country's improving economic conditions have led to increased disposable income among the population. This has allowed consumers to allocate a greater portion of their budget towards healthcare and pharmaceutical products, including analgesics. Furthermore, the government of Malawi has implemented policies and initiatives to improve access to healthcare services, including the provision of essential medicines. This has created a conducive environment for the growth of the Analgesics (Pharmacies) market, as pharmacies play a crucial role in ensuring the availability and accessibility of analgesics to the population. In conclusion, the Analgesics (Pharmacies) market in Malawi is witnessing significant growth and development. Customer preferences for analgesics purchased from pharmacies, the increasing demand for OTC and natural analgesics, as well as the reliance on private pharmacies due to the limitations of the public healthcare system, are driving the market's growth. Additionally, improving economic conditions and government initiatives to enhance access to healthcare services are contributing to the expansion of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)